Despite dedicated efforts across the biopharmaceutical industry to streamline clinical development, clinical trials remain complex, costly, and time-consuming. These challenges are compounded by an increasingly
Innovation is flourishing in the biopharmaceutical industry. Over the past decade, the volume of Phase I candidates in the drug development pipeline has grown by
The competition among biopharmaceutical companies for externally sourced assets is heating up. Despite recent successes delivering innovative therapies at a faster pace and achieving solid
Life sciences is on the cusp of a new era of innovation. The convergence of breakthrough technologies, widespread access to data, and deeper insights into
Discovering and developing effective new medicines has always been difficult—but it is particularly hard today. The world’s biopharmaceutical companies face challenges ranging from rising R&D
In this episode of Eureka!, a McKinsey podcast on innovation in life sciences R&D, cohosts Navraj Nagra, Alex Devereson, and Erika Stanzl speak with Howard
At a glance The ‘empowerment line’ measures progress toward a world where everyone’s essential needs are met. About 40 percent of the global population lives
Play the interactive version, or if you like putting pen(cil) to paper, download and print when you’re ready to engage. Check back each Tuesday for
Despite some notable moments, 2024 was a bit of a bumpy ride when it came to technology. Concerns about AI created a hive of regulatory
Beauty is no longer in the eye of the beholder; it’s at the fingertips of the generative AI (gen AI) prompter. Gen AI could add
